The endocannabinoid AEA (10 μM) reduced the growth of cholangiocarcinoma in vivo model, upregulating Wnt5a expression with subsequent activation of receptor tyrosine kinase-like orphan receptor 2 (Ror2) and c-Jun N-terminal kinase JNK [43]. Here, ROR2 is linked to cholangiocarcinoma.